Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : JPMorgan Adjusts Thermo Fisher Scientific PT to $700 From $600, Maintains Overweight Rating

09/20/2021 | 09:41am EDT


ę MT Newswires 2021
All news about THERMO FISHER SCIENTIFIC
05:56aTHERMO FISHER SCIENTIFIC : UK Competition Regulator to Launch Inquiry Into Thermo Fisher's..
MT
12:57aUK Watchdog to Investigate Thermo Fisher's Planned Acquisition of PPD
DJ
10/11THERMO FISHER SCIENTIFIC : to Hold Earnings Conference Call on Wednesday, October 27, 2021
PR
10/07Q LINEA : ASTar launched in Europe
AQ
10/07Thermo Fisher Scientific Officially Launches ASTar for the European Market
CI
10/07Health Care Stocks Gain Premarket Thursday
MT
10/07THERMO FISHER SCIENTIFIC : Prices Notes Offering Totaling 5.25 Billion Euros
MT
10/07Thermo Fisher Scientific and Q-Linea Launch ASTar System, A Rapid Antimicrobial Suscept..
CI
10/06THERMO FISHER SCIENTIFIC : Prices Offering of Euro-Denominated Senior Notes
PR
10/05Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance
CI
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2021 36 041 M - -
Net income 2021 7 156 M - -
Net Debt 2021 18 490 M - -
P/E ratio 2021 32,0x
Yield 2021 0,17%
Capitalization 227 B 227 B -
EV / Sales 2021 6,82x
EV / Sales 2022 6,15x
Nbr of Employees 80 000
Free-Float 89,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 577,35 $
Average target price 642,29 $
Spread / Average Target 11,2%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors